Telomir Pharmaceuticals, Inc.
TELO · XNASCIK 1971532fmd_0NZDJMAYX54C37V8ZBYZXJ5PCAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2026, 16 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading